Log in or Sign up for Free to view tailored content for your specialty!
Raynaud’s Syndrome News
FDA grants orphan drug designation to calcium channel blocker for systemic sclerosis
The FDA has granted orphan drug designation to AISA-021, a fourth-generation calcium channel blocker, for the treatment of systemic sclerosis, according to a press release from Aisa Pharma.
Imaging, functional tests can help ‘tease out’ fast vs slow myositis progressors
SAN DIEGO — Imaging and symptom rating scales offer physicians ample opportunity to follow patients with suspected myositis and “tease out” fast vs. slow progressors, noted a speaker at the 2023 Congress of Clinical Rheumatology West.
‘A plethora of emerging treatments’ coming for idiopathic inflammatory myopathies
SAN DIEGO — Clinical trials exploring intravenous immunoglobulin and Janus kinase inhibition headline a robust pipeline for idiopathic inflammatory myopathies, according to a speaker at the 2023 Congress of Clinical Rheumatology West.
Log in or Sign up for Free to view tailored content for your specialty!
Automated nailfold analysis distinguishes systemic sclerosis from normal capillaries
A fully automated analysis of nailfold images was able to distinguish patients with systemic sclerosis from those with normal capillaries at least as well as human experts, according to data published in Rheumatology.
Raynaud’s Awareness Month focuses on symptoms in extremities
One of the most common manifestations of Raynaud’s syndrome is noticeable in the extremities through numbness, discoloration and pain during the cold weather months, according to the Raynaud’s Association.
Vasodilators underused for Raynaud's phenomenon, early systemic sclerosis in veterans
Vasodilator therapy may be underused for Raynaud’s phenomenon and very early systemic sclerosis in U.S. veterans deployed in post-9/11 military operations, according to data published in BMC Rheumatology.
Virtual exercise classes safe, effective in patients with musculoskeletal disease
Hour-long, virtual exercise classes that cover Pilates, yoga and tai chi are safe and improved health outcomes in patients with musculoskeletal disease, according to data presented at ACR Convergence 2021.
Healio launches rheumatology quiz platform, Rheum + Boards
Healio announced the launch of Rheum and Boards, a quiz-based, online learning resource for rheumatologists, according to a Healio press release.
'Avoid cold and reduce stress' to minimize risk for Raynaud’s phenomenon
Avoiding cold and reducing stress are key to minimizing Raynaud’s phenomenon events, while “good, generic wound care” can be effective in even the most complicated cases, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.
Sclerodactyly, Raynaud's, ANA-positivity 'made the diagnosis' for systemic sclerosis
Given the potential for false-positives in Scl-70 antibody testing for systemic sclerosis, many clinicians have overlooked the trio of classic signs and symptoms that would have otherwise “made the diagnosis,” according to a presenter here.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read